Summit Global Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Summit Global Investments’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,427	Closed	-$682K	–	620
2023 Q3	$682K	Buy	+3,427	New	+$810K	0.05%	287
2023 Q2	–	Sell	-4,660	Closed	-$1.01M	–	642
2023 Q1	$1.01M	Buy	4,660 +1,210	+35%	+$236K	0.08%	235
2022 Q4	$709K	Sell	3,450 -900	-21%	-$228K	0.06%	255
2022 Q3	$1.21M	Sell	4,350 -540	-11%	-$137K	0.11%	178
2022 Q2	$935K	Buy	4,890 +87	+2%	+$15.4K	0.08%	229
2022 Q1	$996K	Buy	4,803 +103	+2%	+$17K	0.07%	238
2021 Q4	$838K	Buy	+4,700	New	+$927K	0.05%	264

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Summit Global Investments's SWAV Position: Q4 2023 in Review

Summit Global Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 3,427 shares — an estimated $682K sold.

Summit Global Investments first reported a position in SWAV in Q4 2021 and held it in 7 quarters. The position peaked at $1.21M in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

Summit Global Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Summit Global Investments sold 3,427 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $682K.
Summit Global Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Summit Global Investments's Shockwave Medical, Inc. Common Stock position peaked at $1.21M in Q3 2022.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Summit Global Investments's 13F filing for Q4 2023, filed 6 Feb 2024.